CEL-SCI
CVM | AMEX
$1.66
+$0.38 (+29.69%)
At close: Nov 16, 2026, 4:00 PM ET
$1.67
+$0.01 (+0.60%)
After-hours:
Nov 16, 2026, 7:52 PM ET
+29.69%
(1D)No price chart data available for 1D timeframe.
Rating
24.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #946/1021 (Top 93%)
Key Statistics
Market Data
Market Cap $29.2M
1D Range
1.30 1.75
52W Range
0.97 7.67
Valuation (TTM)
PE -0.64
PB 2.67
EV/EBITDA -1.65
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Cash Flow
FCF Yield -57.4%
SBC Adj. FCF Yield -63.5%
SBC Impact -10.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 62.4% |
5.6%
FCF 3Y | 5Y 6.7% |
5.5%
Returns
ROA -106.3%
ROE -202.1%
ROIC -117.4%
Financial Health
Net Cash
$6.53M
Current Ratio 1.48
Interest Coverage -50.19
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is curren...
Sector Healthcare
Industry Biotechnology
Employees 43
IPO Date Dec 8, 1983
Website cel-sci.com
Fiscal Year October - September
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CVM